Business Description
Physiomics PLC
ISIN : GB00BDR6W943
Total Employee Number:
10Description
Physiomics PLC is a United Kingdom-based firm that provides consulting services to biopharmaceutical companies and research institutes in the areas of outsourced modelling and simulation (quantitative pharmacology), biometrics, and data science (bioinformatics). Its business activities involve the use of industry-standard technologies and a proprietary technology platform called Virtual Tumour. The company has three service lines: Biometrics, Modelling and Simulation (Quantitative Pharmacology) and Personalised Medicine. It derives revenue from the UK, the European Union and Switzerland.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.7 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -5.71 | |||||
Beneish M-Score | -0.99 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -30.7 | |||||
3-Year EBITDA Growth Rate | 20.6 | |||||
3-Year EPS without NRI Growth Rate | 12.6 | |||||
3-Year FCF Growth Rate | 20.6 | |||||
3-Year Book Growth Rate | -41.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 77.04 | |||||
9-Day RSI | 67.89 | |||||
14-Day RSI | 62.87 | |||||
12-1 Month Momentum % | -75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.3 | |||||
Quick Ratio | 3.3 | |||||
Cash Ratio | 1.56 | |||||
Days Sales Outstanding | 98.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -46 | |||||
Shareholder Yield % | -25.22 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -56.24 | |||||
Net Margin % | -50.89 | |||||
EBITDA Margin % | -55.09 | |||||
FCF Margin % | -48.91 | |||||
OCF Margin % | -48.91 | |||||
ROE % | -96.81 | |||||
ROA % | -73.71 | |||||
ROIC % | -224.34 | |||||
3-Year ROIIC % | 250.65 | |||||
ROC (Joel Greenblatt) % | -412.6 | |||||
ROCE % | -106.79 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.31 | |||||
PB Ratio | 5.23 | |||||
EV-to-EBIT | -3.62 | |||||
EV-to-EBITDA | -3.69 | |||||
EV-to-Revenue | 2.04 | |||||
EV-to-Forward-Revenue | 1.18 | |||||
EV-to-FCF | -4.08 | |||||
Price-to-Median-PS-Value | 0.55 | |||||
Earnings Yield (Greenblatt) % | -27.61 | |||||
FCF Yield % | -21.18 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Physiomics PLC Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.104 | ||
| EPS (TTM) (€) | -0.002 | ||
| Beta | 1.3911 | ||
| 3-Year Sharpe Ratio | 0.1 | ||
| 3-Year Sortino Ratio | 0.25 | ||
| Volatility % | 328.18 | ||
| 14-Day RSI | 62.87 | ||
| 14-Day ATR (€) | 0.001359 | ||
| 20-Day SMA (€) | 0.00325 | ||
| 12-1 Month Momentum % | -75 | ||
| 52-Week Range (€) | 0.0005 - 0.011 | ||
| Shares Outstanding (Mil) | 453.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Physiomics PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Physiomics PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-11-18 10:30 | In 113 days | ||
| Annual report for 2026 | 2026-11-13 | In 107 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-10-01 11:00 | In 65 days | ||
| Fourth quarter earnings results for 2026 | 2026-09-29 | In 62 days | ||
| Second quarter earnings results for 2026 | 2026-02-16 | 0.00 (+0.00%) | ||
| General meeting for 2025 | 2025-11-18 10:30 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2025-11-13 | 0.00 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2025-10-01 11:00 | 0.00 (-25.00%) | ||
| Fourth quarter earnings results for 2025 | 2025-09-29 | 0.00 (+0.00%) | ||
| Second quarter earnings conference call for 2025 | 2025-03-10 12:00 | 0.00 (-25.00%) |
Show
Entries
Physiomics PLC Frequently Asked Questions
What is Physiomics PLC(STU:RVW1)'s stock price today?
The current price of STU:RVW1 is €0.01. The 52 week high of STU:RVW1 is €0.01 and 52 week low is €0.00.
When is next earnings date of Physiomics PLC(STU:RVW1)?
The next earnings date of Physiomics PLC(STU:RVW1) is 2026-09-29 Est..
Does Physiomics PLC(STU:RVW1) pay dividends? If so, how much?
Physiomics PLC(STU:RVW1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Physiomics PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers